Pneumonia, Pneumococcal Therapeutic Market ANALYSE DE LA TAILLE ET DU PARTAGE - TENDANCES DE CROISSANCE ET PRÉVISIONS (2024 - 2031)

Pneumonia, Pneumococcal Therapeutic Market is segmented By Route of Administration (Oral, Intravenous, Subcutaneous, Parenteral, Topical), By Molecule Type (Recombinant Fusion Proteins, Small Molecule, Monoclonal Antibody, Peptide Polymer, Gene Therapy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Pneumonia, Pneumococcal Therapeutic Market Leaders

  • Biotest AG
  • Vaxcyte, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc.
*Disclaimer: Major players are listed in no particular order.

Pneumonia, Pneumococcal Therapeutic Market - Company List

  • Biotest AG
  • Vaxcyte, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Sanofi
  • Johnson & Johnson
  • Astellas Pharma Inc.
  • CSL Limited
  • Mitsubishi Tanabe Pharma Corporation
  • Bavarian Nordic
  • SutroVax, Inc.